CAS No.: 681492-17-1
Dndi-vl-2098 Catalog No. CSN20217
DNDI-VL-2098 is an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 参考文献
- [1] Thompson AM, O'Connor PD, et al. 7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-b] [1,3] oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral Leishmaniasis. J Med Chem. 2017 May 25;60(10):4212-4233.
- [2] Satam VS, Pedada SR, et al. Development of a Scalable Process for the Synthesis of DNDI-VL-2098: A Potential Preclinical Drug Candidate for the Treatment of Visceral Leishmaniasis. Org Process Res Dev. 2017 Jan 20;21(1):52-59.
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 681492-17-1 | 储存条件 |
|
|
| 分子式 | C14H12F3N3O5 | 运输 | 蓝冰 | |
| 分子量 | 359.26 | 别名 |
